Themes Investment Partners
3
19M
3
1
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main department of described VC is located in the New York.
This organization was formed by Frank Yu.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2013. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Apexigen, Lonestar Heart. The fund has specific favorite in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Themes Investment Partners, startups are often financed by OrbiMed, Neomed Management, Fjord Ventures. The meaningful sponsors for the fund in investment in the same round are WSR Capital, Sycamore Ventures, OrbiMed. In the next rounds fund is usually obtained by OrbiMed, Neomed Management, Meritech Capital Partners.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Investments by industry
- Biotechnology (3)
- Health Care (2)
- Medical (1)
- Therapeutic Devices (1)
- Genetics (1) Show 4 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Apexigen | 06 Aug 2013 | Biotechnology, Health Care, Pharmaceutical, Biopharma | Early Stage Venture | 20M | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.